Prep Amp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prep amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prep Amp Today - Breaking & Trending Today

QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q1 2022 Results - Earnings Call Transcript

QIAGEN N.V. (NYSE:NYSE:QGEN) Q1 2022 Earnings Conference Call April 28, 2022, 10:00 AM ET Company Participants John Gilardi - VP of Corporate Communications and IR Thierry Bernard - CEO. ....

United States , Hong Kong , United Kingdom , Thierry Bernard , Jack Meehan , Matt Sykes , Patrick Donnelly , John Gilardi , Dan Arias , Casey Woodring , Dan Brennan , Asia Pacific , Phoebe Loh , Exchange Commission , Company Participants , Corporate Communications , Goldman Sachs , Sales In Diagnostic Solutions , Nephron Research , Conference Call April , Conference Call , Vice President , Investor Relations , Chief Executive Officer , Roland Sackers , Chief Financial ,

QIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 test offering up to threefold increase in daily lab testing capacity

QIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 test offering up to threefold increase in daily lab testing capacity
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.

Jean Pascal Viola , European Union , Corporate Business Development , Industry News , Prep Amp , Emergency Use Authorization , Universal Transport Media , Senior Vice President , Molecular Diagnostics Business Area , ஜீன் பாஸ்கல் வயல , ஐரோப்பிய தொழிற்சங்கம் , பெருநிறுவன வணிக வளர்ச்சி , தொழில் செய்தி , அவசரம் பயன்பாடு அங்கீகாரம் , உலகளாவிய போக்குவரத்து மீடியா , மூத்தவர் துணை ப்ரெஸிடெஂட் , மூலக்கூறு பரிசோதனை வணிக பரப்பளவு ,

QIAGEN N.V.: QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity

QIAGEN N.V.: QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity
CE-IVD marking for Europe and other countries worldwide, EUA (Emergency Use Application) submission made in the U.S.
Streamlined workflow cuts costs and plastic usage offering time to result of about two hours
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the
artus SARS-CoV-2 Prep&Amp UM Kit which uses a liquid based sample preparation technology to simplify and increase COVID-19 testing throughput. The
artus SARS-CoV-2 Prep&Amp UM Kit has been CE-IVD registered for use in the European Union and other markets and an application for Emergency Use Authorization (EUA) has been submitted to the FDA, allowing commercialization via notification in the US. ....

John Gilardi , Robert Reitze , Jean Pascal Viola , Thomas Theuringer , Phoebe Loh , Exchange Commission , European Union , Life Sciences , Corporate Business Development , Us Securities Exchange , Prep Amp , Emergency Use Application , Frankfurt Prime Standard , Emergency Use Authorization , Universal Transport Media , Senior Vice President , Molecular Diagnostics Business Area , Molecular Diagnostics , Exchange Act , Annual Report , ஜீன் பாஸ்கல் வயல , ஃபோப் லோ , பரிமாற்றம் தரகு , ஐரோப்பிய தொழிற்சங்கம் , வாழ்க்கை அறிவியல் , பெருநிறுவன வணிக வளர்ச்சி ,